AxoGen, Inc.·4

Dec 20, 6:53 PM ET

Leach Kevin 4

4 · AxoGen, Inc. · Filed Dec 20, 2017

Insider Transaction Report

Form 4
Period: 2017-12-18
Leach Kevin
Vice President Marketing
Transactions
  • Award

    Restricted Stock Units

    2017-12-18+1,4001,400 total
    Common Stock (1,400 underlying)
  • Award

    Employee Stock Option (right to purchase)

    2017-12-18+8,2508,250 total
    Exercise: $27.00Exp: 2027-12-18Common Stock (8,250 underlying)
Footnotes (3)
  • [F1]All shares of AxoGen, Inc. common stock underlying the employee stock option will be fully vested on December 18, 2021 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of AxoGen, Inc. common stock.
  • [F3]All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 18, 2021 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 18, 2019 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -